Boehringer Ingelheim Preclinial Trial Collaboration

At Biorizon Consulting, we lead the way in preclinical trial innovation. Our expertise is exemplified by a landmark collaborations led by Laura over 4+ years in collaboration with Boehringer Ingelheim. From conception to completion, Laura spearheaded every phase of this pioneering trial—starting from scratch, designing the study, managing implementation, navigating regulatory affairs, and presenting the groundbreaking results at a global webinar.

This project highlighted our advanced approach, integrating cutting-edge translational research methodologies, patient samples, and state-of-the-art diagnostic techniques like echocardiography. Our comprehensive services, including Therapeutic Needs Assessment, Early Indication Selection, Comprehensive Indication Assessment, and Market Trend Analysis, ensure strategic advancements in drug development.

With Laura's leadership and our commitment to innovation, Biorizon Consulting transforms scientific insights into actionable strategies, driving success in preclinical research and setting new industry benchmarks.